Search

everythinglearnresearchcommunity

for

Search:↓

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

Low-dose isotretinoin and erythromycin effectively treated hair loss in two young sisters.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Pulsed infrared laser can effectively reduce symptoms of pseudofolliculitis barbae.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Modified laparoscopic sleeve gastrectomy effectively controls diabetes and treats obesity with minimal complications.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Bariatric surgery helps with weight loss but can cause complications and nutritional deficiencies.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

PRP treatment may help with alopecia areata, especially in newer cases.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Biological therapy boosts the immune system to effectively fight melanoma.

The new system helps detect and track early female hair loss better.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

A rare scalp infection in a 66-year-old woman was successfully treated, leading to full hair regrowth.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Women with both type 2 diabetes and PCOS have worse metabolic issues but milder reproductive symptoms after sleeve gastrectomy.

Targeting non-Smad pathways in TGF-β signaling may improve keloid treatment.